Sophie Allauzen

The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman.

Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements.

Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium.

LHGP Asset Management LLP (Private Equity) (LHGP Asset Management) is a private equity arm of Lion's Head Global Partners LLP founded in 2018. The firm is headquartered in Westminster, United Kingdom.

Frontier Nutrition, Inc. develops and manufactures fortified packaged food. Its recipes are localized for traditional diets, taste, and nutrition. The company was founded by Eddie Bearnot and Tanveer Ali on August 18, 2016 and is headquartered in DE.

Truvian Sciences, Inc. engages in the provision of healthcare services. It offers automated benchtop system which produces lab-accurate results for a full suite of tests from a small sample of blood. Its product features include compact and fully automated, dry reagent technology, and fast accurate results. The company was founded by Dena Marrinucci, Mark Bowles and Kim Puloma Kamdar in 2015 and is headquartered in San Diego, CA.

Pleno, Inc. is a company that specializes in multi-omic instrument platform technology for clinical testing and biomedical research. The company is based in San Diego, CA and was founded by Pieter van Rooyen, who has been the CEO since incorporation. The company's proprietary hypercoding™ technology uses signal processing techniques to provide targeted biological information with exceptional scale, precision, and performance.

IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV.

VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

InDevR, Inc. develops and delivers analytical tools for detection and characterization of biological molecules and microorganisms. The firm offers on the ampliPHOX Colorimetric Detection platform and Custom Arrays to enable its customers a low risk means to explore the high utility of focused microarrays. The company was founded by Kathy L. Rowlen, Laura Kuck and John W. Birks in 2003 and is headquartered in Boulder, CO.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023.

Lynx Biosciences, Inc. develops a cytomics-based platform technology. The company is headquartered in San Diego, CA.

Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone.

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

RH Capital LLC (RH Capital) is a venture capital subsidiary of RHIA Ventures, founded in the year 2019 by Lisa Hammann Bowers, Elizabeth Bailey, and Stasia Obremskey. The firm headquartered in San Francisco, California.

Acrobatiq, Inc. provides platform for online learning and consulting services. The firm offers Smart Author, adaptive learning, learning analytics, learning optimization, and professional services. The company was founded by Alison M. Pendergast, Eric Frank, and William L. Guttman in 2013 and is headquartered in Pittsburgh, PA.

X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY.

Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA.

Resurge International operates surgical care facilities for poor children and adults.

Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA.

54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023.

ChromaCode, Inc. develops software and manufactures laboratory instruments. It uses digital signal processing to improve clinical molecular analysis. The company was founded by Aditya Rajagopal, Alexander G. Dickinson, Axel Scherer, and Gregory J. Gosch in 2012 and is headquartered in Carlsbad, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida.